BUMETANIDE Side Effects

6988636-5 | Asthenia, Bradycardia, Hypotension, Hypothermia, Lip Swelling, Tachypnoea
on Sep 02, 2010 Female patient from UNITED KINGDOM , 88 years of age, was diagnosed with pulmonary oedema, senile psychosis, cellulitis (What is cellulitis?), rales, oedema peripheral and was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bradycardia, hypotension, hypothermia (What is hypothermia?), lip swelling, tachypnoea. Bumetanide dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

6716911-8 | Colitis, Gastrointestinal Disorder, Proctalgia
Patient was taking Bumetanide (View Usage). Patient had the following side effects: colitis, gastrointestinal disorder, proctalgia on May 06, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 175.0 lb, . Bumetanide dosage: .

6713333-0 | Dizziness, Dyspnoea, Gait Disturbance, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Hypoparathyroidism, Intention Tremor, Muscular Weakness
Adverse event was reported on May 03, 2010 by a Male patient taking Bumetanide (View Usage) (Dosage: ) was diagnosed with dyspnoea, oesophagitis ulcerative, hypokalaemia, hypocalcaemia, hypomagnesaemia, gastrooesophageal reflux disease and. Location: NETHERLANDS , 82 years of age, After Bumetanide was administered, patient had the following side effects: dizziness (What is dizziness?), dyspnoea, gait disturbance, hypocalcaemia, hypokalaemia, hypomagnesaemia, hypoparathyroidism, intention tremor, muscular weakness. During the same period patient was treated with ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), POTASSIUM (View Potassium Review and Potassium Label ), CALCIUM (View Calcium Review and Calcium Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6691552-X | Dizziness, Dyspnoea, Gait Disturbance, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Hypoparathyroidism, Intention Tremor, Muscular Weakness
on Apr 13, 2010 Male patient from NETHERLANDS , 82 years of age, was diagnosed with dyspnoea, oesophagitis ulcerative, hypokalaemia, hypocalcaemia, hypomagnesaemia and was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dyspnoea, gait disturbance, hypocalcaemia, hypokalaemia, hypomagnesaemia, hypoparathyroidism, intention tremor, muscular weakness. Bumetanide dosage: . During the same period patient was treated with ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), POTASSIUM (View Potassium Review and Potassium Label ), CALCIUM (View Calcium Review and Calcium Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.


6649532-6 | Blood Creatine Increased, Blood Urea Increased
on Mar 24, 2010 Male patient from UNITED STATES , 54 years of age, weighting 352.7 lb, was diagnosed with cardiac failure congestive, diastolic dysfunction, hypertension and was treated with Bumetanide (View Usage). Patient had the following side effects: blood creatine increased, blood urea increased. Bumetanide dosage: 2 Mg Bid Po. During the same period patient was treated with LISINOPRIL (40 Mg Every Day Po) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6596461-2 | Angioedema
Patient was taking Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: angioedema on Feb 22, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with cardiac failure congestive and. Bumetanide dosage: 2 Mg Bid Po. Patient was hospitalized.

6569144-2 | Metabolic Alkalosis, Respiratory Alkalosis
Adverse event was reported on Feb 01, 2010 by a Male patient taking Bumetanide (View Usage) (Dosage: 2 Mg Bid Po) was diagnosed with hypertension, oedema and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: metabolic alkalosis, respiratory alkalosis. During the same period patient was treated with METHIMAZOLE (10 Mg Every Day Po) (View Methimazole Review and Methimazole Label ). Patient was hospitalized.

6538946-0 | Erythema
on Jan 14, 2010 Male patient from UNITED STATES , 82 years of age, was diagnosed with cardiac failure congestive and was treated with Bumetanide (View Usage). Patient had the following side effects: erythema. Bumetanide dosage: 1 Tab Every Day Po.

6425270-X | Balance Disorder, Dizziness, Dry Mouth, Dysarthria, Dyspnoea, Hypotension, Muscular Weakness, Nausea, Pruritus
on Oct 30, 2009 Male patient from UNITED STATES , weighting 168.0 lb, was diagnosed with cardiac failure congestive, oedema and was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: balance disorder, dizziness (What is dizziness?), dry mouth, dysarthria, dyspnoea, hypotension, muscular weakness, nausea (What is nausea?), pruritus. Bumetanide dosage: .

6203726-2 | Blood Potassium Decreased, Myalgia
Patient was taking Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, myalgia on May 26, 2009 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with oedema, pulmonary oedema and. Bumetanide dosage: 1-2mg Per Hour Continuous Iv Drip.

6129128-5 | Burning Sensation
Adverse event was reported on Mar 23, 2009 by a Male patient taking Bumetanide (View Usage) (Dosage: 1mg X1 Iv) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , weighting 161.4 lb, Patient had the following side effects: burning sensation.

6127782-5 | Burning Sensation
on Mar 20, 2009 Female patient from UNITED STATES , weighting 133.6 lb, was diagnosed with cardiac failure congestive and was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: burning sensation. Bumetanide dosage: 1mg X1 Iv.

6127781-3 | Burning Sensation
on Mar 20, 2009 Male patient from UNITED STATES , weighting 168.0 lb, was diagnosed with cardiac failure congestive and was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation. Bumetanide dosage: 1mg X1 Iv.

6127778-3 | Burning Sensation
Patient was taking Bumetanide (View Usage). Patient had the following side effects: burning sensation on Mar 20, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 160.5 lb, was diagnosed with cardiac failure congestive and. Bumetanide dosage: 1mg X1 Iv.

6127777-1 | Injection Site Irritation
Adverse event was reported on Mar 20, 2009 by a Male patient taking Bumetanide (View Usage) (Dosage: 1mg X1 Iv) was diagnosed with cardiac failure and. Location: UNITED STATES , weighting 154.3 lb, After Bumetanide was administered, patient had the following side effects: injection site irritation.

6042033-8 | Gout
on Jan 08, 2009 Female patient from UNITED KINGDOM , 79 years of age, weighting 224.9 lb, was diagnosed with hypertension and was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: gout (What is gout?). Bumetanide dosage: .

5915350-7 | Chronic Obstructive Pulmonary Disease, Diarrhoea, Hypocalcaemia, Hypokalaemia, Hypomagnesaemia, Hypophosphataemia, Vomiting
on Sep 29, 2008 Female patient from UNITED KINGDOM , 78 years of age, was treated with Bumetanide (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, diarrhoea, hypocalcaemia, hypokalaemia, hypomagnesaemia, hypophosphataemia, vomiting. Bumetanide dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), HYOSCINE HBR HYT (View Hyoscine Hbr Hyt Review and Hyoscine Hbr Hyt Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), LOSARTAN (View Losartan Review and Losartan Label ). Patient was hospitalized.

5848604-3 | Wheezing
Patient was taking Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: wheezing on Aug 15, 2008 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 233.7 lb, was diagnosed with renal transplant and. Bumetanide dosage: 2 Mg Q 12 Hours Iv. Patient was hospitalized.

5840141-5 | Asthenia, Fatigue, Heart Rate Irregular
Adverse event was reported on Aug 07, 2008 by a Female patient taking Bumetanide (View Usage) (Dosage: 1 Tablet Per Day) was diagnosed with blood pressure (What is blood pressure?) and. Location: UNITED STATES , 78 years of age, weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: asthenia, fatigue, heart rate irregular.

5808635-6 | Bradycardia, Dehydration, Renal Failure Acute
on Jul 09, 2008 Male patient from UNITED STATES , 61 years of age, was diagnosed with cardiac failure congestive and was treated with Bumetanide (View Usage). Patient had the following side effects: bradycardia, dehydration, renal failure acute. Bumetanide dosage: 0.5 Mg Prn Iv. During the same period patient was treated with FUROSEMIDE (20 Mg Once Iv) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5778488-3 | Hypokalaemia
on Jun 18, 2008 Male patient from UNITED STATES , 63 years of age, weighting 281.3 lb, was diagnosed with ascites and was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: hypokalaemia. Bumetanide dosage: 2 Mg Bid Po. During the same period patient was treated with METOLAZONE (5 Mg Po) (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

5763796-2 | Back Pain
Patient was taking Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?) on Dec 03, 2007 from UNITED STATES Additional patient health information: Female patient , 88 years of age, . Bumetanide dosage: (2 Mg). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CARTEOLOL HYDROCHLORIDE (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

5683570-5 | Completed Suicide
Adverse event was reported on Jan 25, 2008 by a Male patient taking Bumetanide (View Usage) (Dosage: Oral) . Location: UNITED STATES , 64 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with METFORMIN HCL (Oral) (View Metformin Hcl Review and Metformin Hcl Label ), EZETIMIBE/SIMVASTATIN (EZETIMIBE) (Oral) (View Ezetimibe/simvastatin (ezetimibe) Review and Ezetimibe/simvastatin (ezetimibe) Label ), POTASSIUM (POTASSIUM NOS) (Oral) (View Potassium (potassium Nos) Review and Potassium (potassium Nos) Label ), ACETAMINOPHEN (Oral) (View Acetaminophen Review and Acetaminophen Label ).

5634315-6 | Unevaluable Event
on Feb 01, 2007 Female patient from UNITED STATES , 29 years of age, was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: unevaluable event. Bumetanide dosage: .

5607620-7 | Acute Prerenal Failure, Asthenia, Blood Potassium Increased, Dehydration, Dry Skin, Electrocardiogram Qrs Complex Prolonged, Electrolyte Imbalance, Gait Disturbance, Hypotension
on Jan 28, 2008 Male patient from UNITED STATES , 82 years of age, weighting 194.9 lb, was diagnosed with hypertension and was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, asthenia, blood potassium increased, dehydration, dry skin, electrocardiogram qrs complex prolonged, electrolyte imbalance, gait disturbance, hypotension. Bumetanide dosage: 1 Tablet Daily Po. During the same period patient was treated with KCL TAB (1 Tablet Daily Po) (View Kcl Tab Review and Kcl Tab Label ). Patient was hospitalized.

5496910-7 | Bone Disorder, Pain
Patient was taking Bumetanide (View Usage). Patient had the following side effects: bone disorder, pain (What is pain?) on Oct 23, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 220.0 lb, was diagnosed with hypertension and. Bumetanide dosage: 1 Mg Qd Po.

5484042-3 | Asthenia, Disease Progression, Dyspnoea
Adverse event was reported on Aug 21, 2007 by a Female patient taking Bumetanide (View Usage) (Dosage: ) was diagnosed with hypertension, cardiomyopathy (What is cardiomyopathy?), metastatic renal cell carcinoma and. Location: UNITED STATES , 51 years of age, After Bumetanide was administered, patient had the following side effects: asthenia, disease progression, dyspnoea. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), TEMSIROLIMUS (View Temsirolimus Review and Temsirolimus Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

5459896-7 | Blood Pressure Systolic Decreased, Bradycardia, Diarrhoea, Hyperkalaemia, Renal Failure Acute, Shock, Unresponsive To Stimuli
on Sep 07, 2007 Female patient from UNITED KINGDOM , 67 years of age, was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic decreased, bradycardia, diarrhoea, hyperkalaemia, renal failure acute, shock, unresponsive to stimuli. Bumetanide dosage: . During the same period patient was treated with ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

5408257-5 | Dehydration, Hypokalaemia
on Aug 06, 2007 Male patient from UNITED STATES , 80 years of age, weighting 220.7 lb, was diagnosed with hypertension and was treated with Bumetanide (View Usage). Patient had the following side effects: dehydration, hypokalaemia. Bumetanide dosage: 2mg Bid Po. Patient was hospitalized.

5404472-5 | Blood Creatinine Increased, Blood Potassium Increased, Electrolyte Imbalance, Renal Failure
Patient was taking Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, electrolyte imbalance, renal failure on Oct 11, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 91 years of age, was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?), ill-defined disorder, atrial fibrillation (What is atrial fibrillation?) and. Bumetanide dosage: . During the same period patient was treated with DICLOFENAC (DICLOFENAC) (Topical) (View Diclofenac (diclofenac) Review and Diclofenac (diclofenac) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (Oral) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5362370-X | Cardiac Failure Chronic
Adverse event was reported on Jun 12, 2007 by a Male patient taking Bumetanide (View Usage) (Dosage: Daily Dose: 2 Milligram(s)) was diagnosed with ill-defined disorder, diabetic neuropathy and. Location: IRELAND , 59 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure chronic. During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ), METOPROLOL SUCCINATE (Daily Dose: 25 Milligram(s)) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), DIGOXIN (Daily Dose: .125 Milligram(s)) (View Digoxin Review and Digoxin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), INSULIN (View Insulin Review and Insulin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5347076-5 | Cardiac Failure Congestive, Epistaxis, Haemoptysis, Pneumonia, Sinus Headache
on May 22, 2007 Female patient from UNITED STATES , 65 years of age, weighting 229.1 lb, was diagnosed with fluid retention and was treated with Bumetanide (View Usage). Patient had the following side effects: cardiac failure congestive, epistaxis, haemoptysis, pneumonia (What is pneumonia?), sinus headache. Bumetanide dosage: 1 Mg, Bid, Oral. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LIPITOR /NET/ (ATORVASTATIN CALCIUM) (View Lipitor /net/ (atorvastatin Calcium) Review and Lipitor /net/ (atorvastatin Calcium) Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), WARFARIN (WARFARN) (View Warfarin (warfarn) Review and Warfarin (warfarn) Label ). Patient was hospitalized.

5317945-0 | Blood Creatinine Increased, Renal Disorder
on May 04, 2007 Male patient from UNITED STATES , weighting 208.0 lb, was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: blood creatinine increased, renal disorder. Bumetanide dosage: 1 Mg Bid Po. During the same period patient was treated with METOLAZONE (2.5 Mg 3 X / Wk Po) (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

5294245-9 | Epistaxis, Pneumonia, Pulmonary Oedema, Sinus Headache
Patient was taking Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, pneumonia (What is pneumonia?), pulmonary oedema, sinus headache on Apr 09, 2007 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 222.0 lb, was diagnosed with fluid retention and. Bumetanide dosage: 60 Tabs 1 Two Times A Day Po. Patient was hospitalized and became disabled.

5262844-6 | Bradycardia, Diarrhoea, Hyperkalaemia, Renal Failure Acute, Shock
Adverse event was reported on Mar 06, 2007 by a Female patient taking Bumetanide (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 67 years of age, Patient had the following side effects: bradycardia, diarrhoea, hyperkalaemia, renal failure acute, shock. During the same period patient was treated with ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

5252915-2 | Dry Mouth, Headache, Memory Impairment, Photophobia, Photosensitivity Reaction, Skin Discolouration
on Feb 12, 2007 Female patient from NETHERLANDS , 55 years of age, weighting 163.1 lb, was diagnosed with cardiac failure, atrial fibrillation (What is atrial fibrillation?) and was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: dry mouth, headache (What is headache?), memory impairment, photophobia, photosensitivity reaction, skin discolouration. Bumetanide dosage: 1 Mg, Qd, Oral. During the same period patient was treated with SPIRONOLACTONE (25 Mg, Qd, Oral) (View Spironolactone Review and Spironolactone Label ), CORDARONE (1 Df, Qd, Oral) (View Cordarone Review and Cordarone Label ), SELOKEEN ZOC(METOPROLOL SUCCINATE) TABLET, 47.5MG (50 Mg, Qd, Oral) (View Selokeen Zoc(metoprolol Succinate) Tablet, 47.5mg Review and Selokeen Zoc(metoprolol Succinate) Tablet, 47.5mg Label ), NEWACE(FOSINOPRIL SODIUM) TABLET, 10MG (10 Mg, Qd, Oral) (View Newace(fosinopril Sodium) Tablet, 10mg Review and Newace(fosinopril Sodium) Tablet, 10mg Label ), ACENOCOUMAROL (ACENOCOUMAROL) (View Acenocoumarol (acenocoumarol) Review and Acenocoumarol (acenocoumarol) Label ), CRESTOR (View Crestor Review and Crestor Label ).

5238656-6 | Asthenia, Balance Disorder, Dizziness
on Feb 14, 2007 Male patient from UNITED STATES , weighting 206.0 lb, was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, dizziness (What is dizziness?). Bumetanide dosage: 2 Mg Daily. During the same period patient was treated with CLONIDINE (0.2 Mg/24 H Patch) (View Clonidine Review and Clonidine Label ), FELODIPINE (2.5 Mg Daily) (View Felodipine Review and Felodipine Label ), FLUOXETINE (10 Mg Daily) (View Fluoxetine Review and Fluoxetine Label ), LABETALOL (400 Mg Bid) (View Labetalol Review and Labetalol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ACCU CHEK COMFORT CV (GLUCOSE) TEST STRIP (View Accu-chek Comfort Cv (glucose) Test Strip Review and Accu-chek Comfort Cv (glucose) Test Strip Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALBUTEROL/IPRATROP (View Albuterol/ipratrop Review and Albuterol/ipratrop Label ). Patient was hospitalized.

5215630-7 | Bradycardia, Diarrhoea, Hyperkalaemia, Renal Failure Acute, Shock
Patient was taking Bumetanide (View Usage). Patient had the following side effects: bradycardia, diarrhoea, hyperkalaemia, renal failure acute, shock on Jan 18, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 67 years of age, was diagnosed with cardiovascular disorder, angiopathy and. Bumetanide dosage: . During the same period patient was treated with ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5132998-0 | Fall, Renal Failure, Therapeutic Agent Toxicity
Adverse event was reported on Oct 11, 2006 by a Female patient taking Bumetanide (View Usage) (Dosage: ) was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?), atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED KINGDOM , 91 years of age, After Bumetanide was administered, patient had the following side effects: fall (What is fall?), renal failure, therapeutic agent toxicity. During the same period patient was treated with DICLOFENAC SODIUM 50 MG ENTERIC COATED TABLETS (DICLOFENAC) (Topical) (View Diclofenac Sodium 50 Mg Enteric Coated Tablets (diclofenac) Review and Diclofenac Sodium 50 Mg Enteric Coated Tablets (diclofenac) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (Oral) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5129407-4 | Blood Creatine Increased, Blood Potassium Increased, Blood Urea Increased, Fall, Renal Failure, Therapeutic Agent Toxicity
on Jul 27, 2006 Female patient from UNITED KINGDOM , 91 years of age, was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?) and was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased, blood potassium increased, blood urea increased, fall (What is fall?), renal failure, therapeutic agent toxicity. Bumetanide dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

5121781-8 | Cardiac Failure Acute
on Sep 21, 2006 Female patient from UNITED STATES , 75 years of age, weighting 132.9 lb, was diagnosed with cardiac failure congestive, coronary artery disease (What is coronary artery disease?), blood cholesterol increased and was treated with Bumetanide (View Usage). Patient had the following side effects: cardiac failure acute. Bumetanide dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CARVEDILOL (Daily Dose Reported As 6.25 Mg, 2 In 1 Day) (View Carvedilol Review and Carvedilol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

5081022-7 | Fall, Renal Failure, Therapeutic Agent Toxicity
Patient was taking Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: fall (What is fall?), renal failure, therapeutic agent toxicity on Aug 04, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 91 years of age, was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?) and. Bumetanide dosage: . During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5065431-8 | Blood Creatine Increased, Blood Potassium Increased, Blood Urea Increased, Fall, Renal Failure, Therapeutic Agent Toxicity
Adverse event was reported on Jul 27, 2006 by a Female patient taking Bumetanide (View Usage) (Dosage: ) was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?) and. Location: UNITED KINGDOM , 91 years of age, Patient experienced the following unwanted or unexpected effects: blood creatine increased, blood potassium increased, blood urea increased, fall (What is fall?), renal failure, therapeutic agent toxicity. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

5005644-4 | Renal Failure Acute
on May 17, 2006 Male patient from UNITED STATES , 78 years of age, was diagnosed with hypertension, infection (What is infection?) and was treated with Bumetanide (View Usage). Patient had the following side effects: renal failure acute. Bumetanide dosage: 0.5mg Qam. During the same period patient was treated with VALSARTAN (80mg Qd) (View Valsartan Review and Valsartan Label ), BACTRIM DS (1 Tab Bid) (View Bactrim Ds Review and Bactrim Ds Label ), HYOSCYAMINE (View Hyoscyamine Review and Hyoscyamine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), PROPOXYPHENE HYDROCHLORIDE (View Propoxyphene Hydrochloride Review and Propoxyphene Hydrochloride Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), DETROL (View Detrol Review and Detrol Label ). Patient was hospitalized.

4984771-1 | Electrolyte Imbalance, Orthostatic Hypotension, Polyuria
on Apr 26, 2006 Male patient from UNITED STATES , 57 years of age, weighting 224.0 lb, was diagnosed with hypertension, oedema and was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: electrolyte imbalance, orthostatic hypotension, polyuria. Bumetanide dosage: 2 Mg Tid Po. During the same period patient was treated with METOPROLOL TARTRATE (50 Mg Bid Po) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

4958336-1 | Anxiety, Chest Pain, Electrocardiogram St Segment Elevation, Ventricular Tachycardia
Patient was taking Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chest pain (What is chest pain?), electrocardiogram st segment elevation, ventricular tachycardia on Mar 29, 2006 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 233.0 lb, was diagnosed with dyspnoea exertional and. Bumetanide dosage: 2 Mg Q8h Iv. During the same period patient was treated with NOREPINPHRINE 4 MG/4 ML BEDFORD LABORATORIES (None Ordered) (View Norepinphrine 4 Mg/4 Ml Bedford Laboratories Review and Norepinphrine 4 Mg/4 Ml Bedford Laboratories Label ). Patient was hospitalized.

4940108-5 | Bradycardia, Dialysis, Diarrhoea, Electrocardiogram Qrs Complex Prolonged, Hyperkalaemia, Loss Of Consciousness, Renal Failure Acute, Shock
Adverse event was reported on Feb 27, 2006 by a Female patient taking Bumetanide (View Usage) (Dosage: ) was diagnosed with cardiovascular disorder, angiopathy and. Location: UNITED KINGDOM , 67 years of age, Patient had the following side effects: bradycardia, dialysis (What is dialysis?), diarrhoea, electrocardiogram qrs complex prolonged, hyperkalaemia, loss of consciousness, renal failure acute, shock. During the same period patient was treated with ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

4937199-4 | Anaemia, Anion Gap Increased, Blood Chloride Decreased, Blood Sodium Decreased, Condition Aggravated, Diabetes Mellitus Inadequate Control, Hypokalaemia, Hypotension, Renal Impairment
on Mar 07, 2006 Male patient from UNITED STATES , 79 years of age, weighting 214.3 lb, was diagnosed with cardiac failure congestive, hypertension and was treated with Bumetanide (View Usage). After Bumetanide was administered, patient had the following side effects: anaemia, anion gap increased, blood chloride decreased, blood sodium decreased, condition aggravated, diabetes mellitus inadequate control, hypokalaemia, hypotension, renal impairment. Bumetanide dosage: 2mg Qd Po. Patient was hospitalized.

4910884-6 | Hypotension, Syncope
on Feb 08, 2006 Male patient from UNITED STATES , 63 years of age, weighting 359.0 lb, was treated with Bumetanide (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, syncope. Bumetanide dosage: 1 Mg Bid. During the same period patient was treated with ISOSOSORBIDE SA 40 MG BID (40 Mg Bid) (View Isososorbide Sa 40 Mg Bid Review and Isososorbide Sa 40 Mg Bid Label ), LISINOPRIL (40 Mg Daily) (View Lisinopril Review and Lisinopril Label ), METOPROLOL 100MG BID (100mg Bid) (View Metoprolol 100mg Bid Review and Metoprolol 100mg Bid Label ), NIFEDIPINE 60 MG DAILY (60 Mg Daily) (View Nifedipine 60 Mg Daily Review and Nifedipine 60 Mg Daily Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ISOSORBIDE BINITRATE (View Isosorbide Binitrate Review and Isosorbide Binitrate Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NIFEDIOINE (View Nifedioine Review and Nifedioine Label ). Patient was hospitalized.

4906728-9 | Blood Pressure Diastolic Decreased, Bradycardia, Diarrhoea, Electrocardiogram P Wave Abnormal, Electrocardiogram Qrs Complex Prolonged, Hyperkalaemia, Loss Of Consciousness, Renal Failure Acute
Patient was taking Bumetanide (View Usage). Patient had the following side effects: blood pressure diastolic decreased, bradycardia, diarrhoea, electrocardiogram p wave abnormal, electrocardiogram qrs complex prolonged, hyperkalaemia, loss of consciousness, renal failure acute on Mar 29, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 67 years of age, . Bumetanide dosage: . During the same period patient was treated with ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.